Here are the 10-K annual reports from Milestone Scientific, Inc. (MLSS) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-K covers the audited annual report, with the full financial statements, so if you follow MLSS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MLSS filings page.
Milestone Scientific Inc. filed Amendment No. 1 to its annual report for the year ended December 31, 2025. The amendment is purely administrative and is being used to add governance-related exhibits that were inadvertently omitted or partially linked in the original filing.
The company is now including the entire Restated Certificate of Incorporation as Exhibit 3.1 and restoring its Amended and Restated By-laws as Exhibit 3.2. It also adds updated officer certifications under Section 302 of the Sarbanes-Oxley Act. No financial statements or other disclosures from the original report are changed or updated.
Milestone Scientific Inc. files its annual report describing a specialty medical device business focused on computer-controlled drug delivery systems for dental and epidural procedures. The company’s core Dynamic Pressure Sensing® technology underpins its CompuDent®, STA® dental systems and CompuFlo® Epidural System.
Milestone reported operating losses of $5.7 million in 2025 and $6.8 million in 2024 and states there is substantial doubt about its ability to continue as a going concern without additional capital. As of June 30, 2025, non‑affiliate market value was $39.7 million, and as of March 31, 2026, it had 80,453,116 common shares outstanding. The filing highlights reliance on third‑party manufacturers, extensive FDA and international regulation, MDR transition in the EU, and significant reimbursement and healthcare policy risks.